Assessment of Insulin Sensitivity in Type 2 Diabetics Treated With Metformin, Fenofibrate and Their Combination.
Phase of Trial: Phase II/III
Latest Information Update: 24 Aug 2017
At a glance
- Drugs Fenofibrate (Primary) ; Metformin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Sponsors Abbott Laboratories; Fournier Pharma
- 23 Aug 2017 Planned number of patients changed from 8 to 100.
- 25 Feb 2008 Patient numbers amended from 100 to 8.
- 31 Aug 2007 Status change from in progress to discontinued.